Study Evaluating LXR-623 in Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy

In brief

To evaluate the safety and tolerability of a single dose of LXR-623 in healthy subjects.

Key facts

Study ID

NCT00366522

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

Starts

2006-08-01

Expected to finish

2006-09-01

Last updated by the study team

2009-08-07

Who can join

Age: 19 and older, up to 50. Sex: any. Healthy volunteers: accepted.

Where it is running

• Study site — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.